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Abstract Background Pharmacist-led care services
within the hospital pharmacy setting have a significant
impact on efficient drug management processes. The work
of pharmacists is directly associated with the provision of
drugs and medical supplies along with additional clinical,
administrative, organizational and educational duties.
Depending on the country, these practice roles may differ
to a significant extent. Objective The aim of this research
was to explore the role of the hospital pharmacist and the
provision of both clinical and traditional pharmaceutical
services for patients and medical staff in Polish general
hospitals. Setting Hospital pharmacies from all general
hospitals in Poland. Method A cross-sectional study was
conducted, utilizing an anonymous questionnaire as the
research instrument. Heads of hospital pharmacies were
requested to participate in this study and complete the
questionnaire. The survey was initially piloted to improve
the research method. Main outcome measure The types of
pharmaceutical services performed in Polish general hos-
pitals. Results 166 hospital pharmacies took part in this
survey. The overall response rate was 60.8 %. The total
number of full-time equivalent (FTE) professionals
employed within the surveyed hospital pharmacies was
approximately 833. The procurement and distribution of
drugs were identified as pharmaceutical services performed
by most of the participants. The significant majority of
pharmacists were also involved in compounding, adverse
drug reaction monitoring and rational drug management
services. Eleven (7 %) of the responding pharmacists had
direct contact with patients and 7 (4 %) pharmacists took
part in ward rounds. More precise legal regulations
regarding hospital pharmacy practice were measures indi-
cated by most pharmacists as necessary changes required in
the hospital pharmacy system. Conclusion Polish hospital
pharmacists provide various pharmaceutical services. Their
work is closely related with direct provision of drugs.
There is an observed inadequate level of clinical services
provided in comparison to clinical settings in other
countries.
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Impact on practice
• The majority of the pharmaceutical services provided
by hospitals pharmacists are directly associated with
medicines, their production, procurement, distribution
and storage.
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• In comparison to other countries, patient oriented
pharmaceutical services are not a common practice
within Polish general hospitals.
• More precise legal regulations and an increase in
staffing levels within the pharmacy may improve the
quality of services in Polish hospital pharmacy.
Introduction
Pharmacist-led care services within the hospital pharmacy
setting have a significant impact on efficient drug man-
agement processes. According to the European Association
of Hospital Pharmacists (EAHP), the fundamental role of
the hospital pharmacy service is to ‘‘optimize patient out-
comes, by collaboratively working within multidisciplinary
teams in order to achieve responsible use of medicines’’
[1]. In order to promote quality patient care, a hospital
pharmacist’s role comprises of the provision of both clin-
ical pharmacy services and conventional pharmacy ser-
vices i.e. the dispensing and production of medicines [2].
According to the European Society of Clinical Pharmacy,
the clinical pharmacist is responsible for performing
activities focusing on the promotion of rational and
appropriate use of medicinal products and devices [3].
However, depending on the country, the extent to which
these listed roles are performed in practice may differ. For
example, clinical services are more commonly performed
in the US than in Europe. In Europe, only 6 % of phar-
macists carry out services on wards for a minimum of 50 %
of their total work time, whilst in the US 34 % of hospital
pharmacists spend more than 8 h per day on the ward.
Differences are also observed between particular countries
in Europe; in the UK, Ireland and Norway clinical phar-
macy practice is highly developed in comparison to their
counterparts in Eastern Europe [4]. Evidence from other
countries confirms that clinical pharmacy services per-
formed within the following units: intensive care [5, 6],
geriatric [7], oncology [8], internal medicine [8, 10],
pediatrics [11], surgery [12, 13], cardiology [14] and pal-
liative care [15], are beneficial for patients, hospital staff
and the health care system. Pharmacists are also essentially
involved in the detection and prevention of harmful med-
ication errors [16–20] and drug related-problems, including
adverse drug reactions [21–23]. Gerdemann et al. in their
pilot study demonstrated that the presence of pharmacy
interns on the ward increased drug safety by detecting
potential prescribing and documentation errors (e.g. inap-
propriate drug or its dosage, drugs interactions) as well as
improving drug storage conditions on the ward. Further-
more, the interns ward attendance and recommendations
resulted in a high rate of acceptance among physicians and
nurses at the examined German hospital [24]. Apart from
providing clinical services, the fundamental purpose of
hospital pharmacy is to efficiently and safely supply
medicines. Since the cost of medicines ranges from 5 to
12 % of total hospital expenditures in developed countries,
appropriate drug selection and procurement is essential in
the rationalization of therapy, for which pharmacists are
responsible [25]. Additionally, pharmacists must ensure the
adequate distribution, storage, safety and quality of all
medicines at the hospital. At present, 40 % of US hospitals
operate on a decentralized medication use-system and
58 % of hospitals plan to use it in the future [26]. Data
highlights that in comparison to previous years, there is an
observed growth in adapting decentralized models [27, 28].
In contrast, only 6.5 % of hospitals in Europe use a
decentralized distribution model, with 70 % utilizing a
centralized system. However Europe is reporting similar
tendencies as the US in converting to the decentralized
model of practice [29, 30]. In conjunction with distribution
and procurement procedures, medicine production and
compounding is another valuable service performed by the
hospital pharmacy. The production of sterile and non-
sterile products in Europe is performed by 44 and 67.5 %
of hospital pharmacies respectively. However, the com-
pounding of products has seen a considerable decrease in
recent years, dropping from 71 and 92.5 %, for sterile and
non-sterile products respectively from 2000 [30]. Similarly
to other countries, Polish hospital pharmacists frequently
perform professional activities to ensure the safe and effi-
cient use of drugs. It is a requirement that these pharmacy
services are performed in accordance with Polish law
(Pharmaceutical Law and Pharmaceutical Chambers’ Act)
and each hospital’s own rules and regulations. The services
provided by hospital pharmacy specifically pertain to the
use of pharmacotherapy, and involve drug supply, com-
pounding, clinical activities, patient safety, administrative
duties, education as well as scientific research. A prelimi-
nary study conducted at Polish teaching hospitals demon-
strated that all of the Polish pharmacists surveyed were
solely responsible for the ordering and dispensing of
medicines. A significant number of pharmacists were also
actively involved in the compounding of medicines, col-
laborating in drug management processes at the hospital as
well as participating in clinical trials. However, it is
reported that patient oriented clinical activities at teaching
hospitals were rarely performed with 94 % of pharmacists
failing to participate in hospital medical rounds, and 44 %
claiming to have never worked in the capacity of a clinical
pharmacist [31].
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Aim of the study
The aim of this research was to explore the clinical role of
the hospital pharmacist and the associated clinical and
conventional pharmacy services performed within the
hospital setting. The study seeks to further investigate the
level of collaboration between pharmacists and other
medical staff and to identify areas of potential service
improvement in order to understand the necessary future
changes that need to be introduced to Polish general hos-
pital practice.
Ethical approval
The pharmacists are not the direct subjects of this study, as
we have only examined their opinions on current hospital
pharmacy practice. The responses to the survey were
anonymous and all respondents agreed to participate in the
study by completing and returning a written questionnaire.
Method
A cross sectional study was carried out to collect survey
data from a selected population of hospital pharmacists.
The research was performed on a national scale; the heads
of each pharmacy department employed at every general
hospital (teaching and non-teaching) in Poland were
recruited to participate in this research. The total number of
participants was 273. They were chosen from the widely
accessible web database of Health Care Institutions (ac-
cessed 2013). The questionnaire was developed based on
legislation regulating pharmacist services and hospital
pharmacy practice, literature and the researchers own
experience. The survey was anonymous. It was initially
piloted with just the Polish teaching hospitals and corrected
following the feedback [31]. The questionnaire consisted of
both multiple-choice questions and open-ended questions
(the questionnaire is available as a supplementary mate-
rial). The multiple-choice group made up the majority of
questions in the survey, and enabled the collection of
reliable and uniform data and the further application of
statistical methods. The questionnaire along with a letter of
invitation, (which included information about the survey
and a request for participation in this research), was dis-
tributed by Polish Post to predetermined hospitals. The
respondents, as representatives of all professional phar-
macy staff employed at their respective hospital, were
asked to fill-in the questionnaire and return it in the
enclosed envelope by post or by fax or email. The survey
was conducted in 2013.
Subsequent to receiving the results, the Chi square test
and Fisher’s exact test (for small groups) as well as
descriptive statistics were applied to the data. The Chi
square test was applied to test whether the variables
(population of the city in which the hospital is located or
the number of professionals employed at the pharmacy) are
associated with the performance frequency of particular
pharmaceutical services. Additionally, we have used this
test to examine the relationship between the age of phar-
macists and the willingness to introduce any changes into
the hospital pharmacy system. Furthermore, we tested if
the size of the hospital had any influence on the provision
of pharmaceutical care, and whether the level of pharma-
cist experience had any impact on collaborative practice
with other medical staff. Descriptive statistics were used to
summarize the data and show the basic characteristics of
the population. All statistical analyses were calculated with
the use of STATISTICA Version 10 software (StatSoft,
Inc., 2010).
Results
166 out of 273 hospitals took part in this survey (response
rate 60.8 %). Most of the respondents were employed by
large hospitals, characterized by facilities containing more
than 100 beds. Out of the 166 hospitals that were included
in the study, a total number of 833 full-time equivalent
(FTE) professionals were found to be employed in their
respective pharmacies; with an average of 5 ± 4.94 FTE
per pharmacy (median = 4, the range extended from 1 to
39 FTE per pharmacy) (Tables 1, 2).
Table 3 details the types of pharmaceutical services
performed by pharmacists and highlights the differences in
service according to the size of the cities in which the
hospitals are located (number of inhabitants/population)
and the FTE of professional staff in the pharmacies.
The concept of pharmaceutical care was incorporated
into Polish legislation in 2008 and is defined as a docu-
mented practice in which a pharmacist together with the
patient, physician and other healthcare professionals
ensures the appropriate use of pharmacotherapy in order to
achieve positive clinical outcomes that increase the patients
quality of life. As such, this service, as defined by the
aforementioned law, was performed by only 17 out of 166
hospital pharmacies (10 %). The provision of this rela-
tively new service is observed more often at smaller hos-
pitals (5 settings out of 11) than in bigger settings (12 out
of 15) (p = 0.00008). The respondents listed two main
reasons for the poor rates of involvement in pharmaceutical
care, including: lack of time due to an insufficient number
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of pharmacy staff (32, 19 %) and lack of perceived need
for this service from a physicians’ perspective (22, 13 %).
All of the surveyed pharmacists were found to carry out
their work within hospital dispensaries. Only a small
number of pharmacists additionally performed services on
hospital wards and in drug units (15, 2 % respectively). At
162 general hospitals (98 %), the pharmacist was found to
be a member of a Drug and Therapeutics Committee and a
further 22 pharmacists declared to be the president or vice
president of the committee.
Pharmacists were most often found to collaborate pro-
fessionally with the head nurse (151, 91 %), the hospital
director (120, 72 %) and the head of the ward (115, 69 %).
A smaller number of pharmacists claimed to work in
partnership with on–call physicians (39, 23 %) and other
staff (medical director, administrative staff, microbiologist,
physician, and clinical pharmacologist), (32, 19 %). The
main topics of pharmacist consultations with these staff
members are presented in Fig. 1.
Pharmacists with a period of service greater than
10 years within the hospital reported more often that they
collaborated with other medical staff than less experienced
workers (p\ 0.005), (e.g. 106 out of 112 pharmacists with
work experience longer than 10 years collaborate with a
head nurse, whereas 45 out of 53 less experienced workers
collaborate with a head nurse). Clinical pharmacologists
were found to play a minor role at Polish general hospitals,
with only 6 out of 166 (4 %) facilities employing this type
of specialist, and only 3 respondents collaborating with
clinical pharmacologists. In terms of the clinical services
provided, only 11 out of 166 pharmacists (7 %) reported to
having direct contact with patients. According to respon-
dents, these interactions occur during the dispensing of
medicines in special drug programs, during chemotherapy
as well as during outpatient counseling following specialist
medical consultations. Patient counseling by pharmacists
occurred more commonly within hospitals located in big-
ger cities (9 out of 71), than at facilities with smaller
populations (2 out of 91), (p = 0.009, Fisher’s exact test).
154 (93 %) of the surveyed Polish hospital pharmacists do
not participate in multidisciplinary ward rounds. Only 7
(4 %) pharmacists admitted to taking part in ward rounds,
with 2 respondents participating on a regular basis and 5
occasionally. Despite this finding, 54 (33 %) heads of
pharmacy reported that they would like to change the sit-
uation and become involved in ward rounds. However 100
(60 %) pharmacists were not interested in undertaking this
Table 1 Background characteristics of the surveyed hospitals
n = 166 %
Number of beds
C10 B 30 1 1
[30 B 60 2 1
[60 B 100 8 5
[100 154 93
No response 1 1
Average per
pharmacy
The number of full-time equivalent (FTE) professionals employed in
hospital pharmacies
Total 833.4 100 5
PhD, pharmacist 9 1 0.05
Master of pharmacy 372.9 45 2.2
Pharmacy technician 451.5 54 2.7
Table 2 Background characteristics of the heads of hospital
pharmacies
n = 166 %
Age
[30 years B 40 years 34 20
[40 years B 50 years 45 27
[50 years B 60 years 61 37




No response 1 1
Education
PhD, pharmacist 5 3
Master of pharmacy 160 96
No response 1 1
Specialization
Clinical pharmacy 6 4
Hospital pharmacy 41 25
Community pharmacy 111 67
Other 8 5
During the course (not completed) 17 10
Clinical pharmacy 5 3
Hospital pharmacy 7 4
Community pharmacy 3 2
Lack of specialization 26 16
Length of service to the hospital pharmacy
\1 year 2 1
C1 year B 3 years 10 6
[3 years B 10 years 42 25
[10 years 112 67
Direct supervisor
Hospital director 75 45
Vice director 87 52
Other 4 2
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activity. 108 (65 %) respondents subjectively believed that
pharmacists employed within the hospital pharmacy were
not clinical pharmacists at all and only 3 pharmacists (2 %)
were certain that they fulfilled their services as a clinical
pharmacist. Other participants claimed that their clinical
role was rather negligible.
The final section of the survey considers proposals for
change from the respondent’s perspective, which should be
introduced into the hospital pharmacy system to improve
pharmaceutical services. According to 73 (44 %) pharma-
cists, changes to the current system are necessary and 67
(40 %) respondents determined that only minor alterations
Table 3 Types of pharmaceutical services performed at hospital pharmacies in context of the population of the cities in which the hospitals are
located and the number of hospital pharmacy staff
Service Service
provided
Number of pharmacies in
context of the population of the
city in which the hospital is
located
Number of pharmacies











1. Dispensing of drugs and medical devices 166 (100 %) 91 72 76 88
2. Procurement of drugs and medical devices from warehouses 160 (96 %) 88 69 73 85
3. Co-participation in the management of drugs at the hospital 159 (96 %) 86 70 73 84
4. Giving information about action and indication of drugs and
medical devices
153 (92 %) 81 69 69 82
5. Compounding 144 (87 %) 77 64 57 86
6. Co-participation in the rationalization of therapy 117 (70 %) 64 50 50 65
7. Co-participation in adverse drug reaction monitoring 110 (66 %) 52 55 46 63
8. Co-participation in clinical trials at the hospital 60 (36 %) 15 43 11 49
9. Preparing drugs, including cytotoxics in daily doses 33 (20 %) 9 23 4 29
10. Preparing total parenteral nutrition 20 (12 %) 6 14 4 16
11. Preparing solutions for hemodialysis and peritoneal dialysis 4 (2 %) 0 4 0 4
12. Preparing solutions for enteral nutrition 2 (1 %) 0 2 0 2
13. Preparing iv solutions 2 (1 %) 1 1 1 1
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availability of the drug at pharmaceutical market
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The topics that are discussed during hospital pharmacist 
consultations : 
Fig. 1 The topics that are
discussed during hospital
pharmacist consultations
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ought to be made. Alternatively, 22 (13 %) participants
believe that there is no need for any amendments to current
hospital pharmacy practice. Younger pharmacists
(\50 years of age) are more interested in introducing
changes (45 out 78) than older pharmacists (28 out 74),
(p = 0.005). As Fig. 2 shows, more precise legal regula-
tions of the hospital pharmacy system, increased levels of
staff within pharmacies as well as salary increases were
commonly identified by the majority of respondents as
important measures to implement to improve practice.
Pharmacists also listed a number of other changes per-
ceived as being essential in order to advance current
practice. These included: (1) the development of modern
and advanced hospital pharmacy equipment, e.g. systems
unit dose, (2) implementing changes to pharmacist tertiary
education, i.e. the emphasis of the study curriculum should
be shifted from chemical structures to more clinical issues,
(3) providing extra postgraduate education options for
career progression, as well as the (4) employment of staff
holding specialist qualifications and undertaking further
education (clinical pharmacists, pharmacologists).
Discussion
To our knowledge, this is the first time a nationwide study
of this nature has been conducted in our country. A key
reason for undertaking this study was to understand the
necessary future changes needed in Polish hospital phar-
macy that will lead to the increase of delivering quality
pharmaceutical services as well as optimizing patient out-
comes. The presented study was performed on a large
scale—a complete sample of objectives participated in this
research—the heads of hospital pharmacies employed in
each general hospital in the whole of Poland were invited
to participate. Therefore, the findings collected from 60 %
of all general hospitals present a description of the current
status of pharmaceutical service performance within hos-
pitals in our country. Furthermore, in comparison to other
similar studies utilizing questionnaires, the observed pro-
portion of returned surveys is satisfactory [26, 32, 33].
Firstly, a significant number of the investigated hospitals
are large clinical settings that in total, employ more than
eight hundred specialized workers, including: doctors of
pharmacy, pharmacists and pharmacy technicians, whose
activities are described in this study. In regards to the
pharmaceutical services provided by pharmacists, the
supply of medicines for inpatients was provided by the
majority of the pharmacies investigated. This responsibility
may be considered as being one of the elemental tasks of a
pharmacist’s work within the hospital. Additionally, a
number of hospital pharmacies were involved in drug
production and compounding (144/160, 87 %). It is
assumed that the calculated figure encompassed both sterile
and non-sterile products. A 2010 study conducted by
EAHP highlighted that in Poland, the production of non-
sterile drug formulations for inpatients was performed at
85.7 % of pharmacies whereas sterile production was less
common [30]. Thus the obtained result is comparable with
the mentioned survey. In comparison to Europe, where the
average production level of non-sterile medicines is 65.8 %
and decreasing, the Polish level of compounding is high
[30]. Furthermore, the advanced services as e.g. co-par-
ticipation in clinical trials, preparing total parenteral
nutrition as well as the preparation of drugs, including
cytotoxics, in daily doses are more often performed at
hospitals located in big cities than in their counterparts
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Changes that may improve hospital pharmacy system: Fig. 2 Changes that may
improve hospital pharmacy
system according to the
pharmacists
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performance of these services was more common at phar-
macies employing a larger number of professional staff.
In general, the results of the study indicate that clinical
practice in Polish hospital pharmacies is not highly
developed. With reference to patient-oriented activities,
only 10 % of pharmacists admitted to carrying out phar-
maceutical care services, with 15 % stating that they
worked on the hospital wards. Only 4 % of respondents
indicated that they take part in hospital ward rounds, with
two pharmacists out of the entire study population claiming
to participate in rounds on a regular basis. Direct contact
with patients was initiated by a small minority of partici-
pants, and three pharmacists out of 166 regarded them-
selves as being clinical pharmacists. Pharmacists were
found to collaborate most often with the head nurse or the
hospital director, which indicates that these consultations
may involve administrative or organizational issues instead
of clinical ones. In light of these findings the following
question arises: why are clinical services not considered to
be a priority in Polish general hospitals as is observed in
other countries [4]? This problem is complex and requires a
comprehensive approach. Firstly, the majority of pharma-
cists are not sufficiently equipped or prepared to offer
clinical services. Whilst the current Polish curriculum of
pharmacy degrees prepares graduates for work within both
hospital and community pharmacies, the majority of young
pharmacists will gain employment and perform pharmacy
services within the latter setting. Therefore, pharmacy
courses are more focused on the preparation of graduates
for work within community pharmacies, with training
involving for example, classes held at virtual training
pharmacies, where students learn how to cope with patients
in real community pharmacies [34]. Furthermore, during
the 6th year of study, 960 h (6 months) of practice are
required to be performed at a community pharmacy, where
students learn how to dispense prescription and non-pre-
scription drugs, counsel patients, perform administrative
tasks and prepare drugs. According to the law, in some
cases students may have to perform a portion of this
practice (not more than 3 months) within hospital phar-
macy settings. However, it is not mandatory, and most
candidates do not have chance to gain such experience at a
hospital pharmacy. On the other hand, article 44 of the EU
Directive 2005/36/EC deals that the six month period of
training may be undertaken in ‘‘a pharmacy that is open to
the public or in a hospital’’ [35]. In addition to the students
being unable to experience hospital pharmacy practice, as
the study indicates, most of the pharmacists who actually
work within hospital pharmacies do not have a clinical
specialization. Another issue is that some pharmacists are
not willing to engage in clinical activities i.e. they do not
want to take part in a hospital ward rounds and are not
interested in changing the current situation.
Unquestionably, clinical services should be carried out in
direct contact with both patients and medical staff [36, 37].
The data highlighted that the conditions for collaboration
between pharmacists and other medical staff within Polish
settings are not favorable, as only a small number of
pharmacists perform pharmaceutical services on hospital
wards. Lack of time, associated with a shortage of phar-
macy staff, overwhelming levels of duties and a perceived
lack of need for pharmaceutical services were pointed out
by hospital managers as the reasons for poor engagement in
clinical activities. One positive aspect, evidenced in the
results, emphasizes that Polish pharmacists work together
with other medical staff to improve the delivery of health
care, through active participation in Drug and Therapeutic
Committees, which are also established in other countries
[38, 39]. A survey by Tan et al. [38] indicated that senior
medical staff and hospital pharmacists comprise the core of
these committees. Additionally, in some cases, Polish
pharmacists are presidents or vice-presidents of this group.
These pharmacist attitudes indicate their interest and
engagement in rational drug usage and hospital drug
policy.
Finally, the study collected data regarding the respon-
dents’ perspectives on future changes in hospital pharmacy.
It is encouraging, that the majority of hospital managers’,
particularly younger representatives, believe that the Polish
hospital pharmacy system requires remodeling. In the
opinion of 44 % of respondents, these changes should be
extensive. Most of the hospital managers indicated that
changes in legislation, (that should be implemented into
hospital pharmacy law), may improve the performance of
pharmaceutical services. Furthermore, they detailed that an
increase in staffing levels within the pharmacy, (which was
also mentioned as a condition), may increase the provision
of quality pharmaceutical care. This opinion may result
from that fact that pharmacists currently feel that they are
being overwhelmed by duties that include administrative
work and documentation, which are responsibilities that are
not directly associated with clinical pharmacotherapy. It is
worth mentioning, that pharmacists are also implicated in
the economic aspects of medicine usage, and there is a
significant amount of evidence that suggests pharmacist-
initiated interventions have a positive influence on
decreasing therapy costs [40–42].
Study limitation
The results of the survey should be discussed in the context
of some limitations. Firstly, the questionnaire was not
administered orally, but was sent by post. The respondents
could have potentially misunderstood some questions, and
did not have a chance to clarify them with the researcher.
Next, the questionnaire was not detailed and occupied one
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page A4, therefore some questions were not extensively
examined. However, the questionnaire was intentionally
designed to be short in format to increase the willingness
and participation of respondents to complete and return it
and obtain a satisfactory response rate.
Conclusion
In conclusion, these findings provide a preview into the
current state of clinical and traditional Polish hospital
pharmacy. In general, hospital pharmacy is more devel-
oped in bigger cities and within pharmacies employing a
larger number of pharmacists. In comparison to other
countries, clinical services in Polish settings should be
more commonly performed. However, some single exam-
ples of patient oriented activities in hospital pharmacy have
been observed. A large number of Polish pharmacists are
involved in activities directly associated with drug man-
agement including compounding, supply of medicines or
participation in Drug and Therapeutic Committees. There
are a variety of adjustments that have been proposed which
may improve Polish hospital pharmacy. The most impor-
tant were changes in law related to hospital pharmacy
practice and increased financing.
Further research focusing on the opinions of other
healthcare providers (physicians, nurses) on the quality of
pharmaceutical services is required to provide a compre-
hensive insight into the current state of Polish hospital
pharmacy practice. This, in turn, improves understanding
on the necessary changes that should be introduced to
hospital pharmacy practice.
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